Correlation Between Aerovate Therapeutics and 1606 Corp

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and 1606 Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and 1606 Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and 1606 Corp, you can compare the effects of market volatilities on Aerovate Therapeutics and 1606 Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 1606 Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 1606 Corp.

Diversification Opportunities for Aerovate Therapeutics and 1606 Corp

0.4

Correlation Coefficient

Aerovate Therapeutics  1606 Corp

Very weak diversification

The 3 months correlation between Aerovate and 1606 is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and 1606 Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 1606 Corp and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 1606 Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 1606 Corp has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 1606 Corp go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and 1606 Corp

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the 1606 Corp. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 8.7 times less risky than 1606 Corp. The stock trades about -0.06 of its potential returns per unit of risk. The 1606 Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  0.90  in 1606 Corp on December 3, 2024 and sell it today you would lose (0.31) from holding 1606 Corp or give up 34.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  1606 Corp

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

1606 Corp

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in 1606 Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, 1606 Corp showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and 1606 Corp

The main advantage of trading using opposite Aerovate Therapeutics and 1606 Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 1606 Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 1606 Corp will offset losses from the drop in 1606 Corp's long position.

The idea behind Aerovate Therapeutics and 1606 Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.